These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 14746039)

  • 61. Screening for cervical cancer: different problems in the developing and the developed world.
    Symonds RP
    Eur J Cancer Care (Engl); 1997 Dec; 6(4):275-9. PubMed ID: 9460347
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cervical carcinogenesis: the role of co-factors and generation of reactive oxygen species.
    Giuliano A
    Salud Publica Mex; 2003; 45 Suppl 3():S354-60. PubMed ID: 14746028
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Advocating for cervical cancer prevention.
    Sherris J; Agurto I; Arrossi S; Dzuba I; Gaffikin L; Herdman C; Limpaphayom K; Luciani S
    Int J Gynaecol Obstet; 2005 May; 89 Suppl 2():S46-54. PubMed ID: 15823267
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Towards an inclusive cervical cancer screening strategy: approaches for reaching socioeconomically disadvantaged women.
    Cava M; Greenberg M; Fitch M; Spaner D; Taylor K
    Can Oncol Nurs J; 1997 Feb; 7(1):14-8. PubMed ID: 9165772
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Evolution of Pathological Techniques for the Screening of Cervical Cancer: A Comprehensive Review.
    Chatterjee PB; Hingway SR; Hiwale KM
    Cureus; 2024 May; 16(5):e60769. PubMed ID: 38903362
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cervical cancer screening coverage in the Americas region: a synthetic analysis.
    Fernández-Deaza G; Serrano B; Roura E; Castillo JS; Caicedo-Martínez M; Bruni L; Murillo R
    Lancet Reg Health Am; 2024 Feb; 30():100689. PubMed ID: 38332935
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Early adoption of innovation in HPV prevention strategies: closing the gap in cervical cancer.
    Mahajan I; Kadam A; McCann L; Ghose A; Wakeham K; Dhillon NS; Stanway S; Boussios S; Banerjee S; Priyadarshini A; Sirohi B; Torode JS; Mitra S
    Ecancermedicalscience; 2024; 18():1762. PubMed ID: 39430092
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Impact of a culturally tailored informative video on cervical cancer: a pilot study with Amazonian women in treatment for cervical cancer.
    Moysés R; Amaral G; Viana J; Benzaken A; Pereira MG
    J Obstet Gynaecol; 2022 Jul; 42(5):1340-1346. PubMed ID: 34781822
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prevention of cervical cancer.
    Farnsworth A; Mitchell HS
    Med J Aust; 2003 Jun; 178(12):653-4. PubMed ID: 12797859
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Multinational approaches to cervical cancer screening: a review.
    Lovejoy NC
    Cancer Nurs; 1996 Apr; 19(2):126-34. PubMed ID: 8635166
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cervical cancer, geographical inequalities, prevention and barriers in resource depleted countries.
    Bogdanova A; Andrawos C; Constantinou C
    Oncol Lett; 2022 Apr; 23(4):113. PubMed ID: 35251344
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Implementation of 'see-and-treat' cervical cancer prevention services linked to HIV care in Zambia.
    Mwanahamuntu MH; Sahasrabuddhe VV; Pfaendler KS; Mudenda V; Hicks ML; Vermund SH; Stringer JS; Parham GP
    AIDS; 2009 Mar; 23(6):N1-5. PubMed ID: 19279439
    [No Abstract]   [Full Text] [Related]  

  • 73. How Should Cervical Cancer Prevention Be Improved in LMICs?
    Gossa W; Fetters MD
    AMA J Ethics; 2020 Feb; 22(2):E126-134. PubMed ID: 32048583
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Advancing cervical cancer prevention initiatives in resource-constrained settings: insights from the Cervical Cancer Prevention Program in Zambia.
    Mwanahamuntu MH; Sahasrabuddhe VV; Kapambwe S; Pfaendler KS; Chibwesha C; Mkumba G; Mudenda V; Hicks ML; Vermund SH; Stringer JS; Parham GP
    PLoS Med; 2011 May; 8(5):e1001032. PubMed ID: 21610859
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Meeting the Global Need for Radiation Therapy in Cervical Cancer-An Overview.
    Gurram L; Kalra B; Mahantshetty U
    Semin Radiat Oncol; 2020 Oct; 30(4):348-354. PubMed ID: 32828390
    [TBL] [Abstract][Full Text] [Related]  

  • 76. 'Smartscopy' as an alternative device for cervical cancer screening: a pilot study.
    Tanaka Y; Ueda Y; Okazawa A; Kakuda M; Matsuzaki S; Kobayashi E; Yoshino K; Kimura T
    BMJ Innov; 2017 Apr; 3(2):123-126. PubMed ID: 28794895
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Molecular oncology testing in resource-limited settings.
    Gulley ML; Morgan DR
    J Mol Diagn; 2014 Nov; 16(6):601-11. PubMed ID: 25242061
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Program evaluation: considerations of effectiveness, efficiency and equity.
    Reinke WA
    J Family Community Med; 1994 Jan; 1(1):61-71. PubMed ID: 23008537
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Technological, institutional, and geographical peripheries: regional development and risk of poverty in the European regions.
    Barbero J; Rodríguez-Crespo E
    Ann Reg Sci; 2022; 69(2):311-332. PubMed ID: 35400802
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Is existing cervical cancer screening proven productive in developing nations: Time to move from the laboratory to community?
    Singh S; Badaya S; Multani MK
    South Asian J Cancer; 2013 Oct; 2(4):242. PubMed ID: 24455648
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.